Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis

Korean J Intern Med. 2011 Sep;26(3):320-7. doi: 10.3904/kjim.2011.26.3.320. Epub 2011 Sep 13.

Abstract

Background/aims: We assessed changes in hemodynamic and arterial stiffness parameters following reductions of dialysate calcium concentrations in patients undergoing hemodialysis.

Methods: In this prospective study, 20 patients on maintenance hemodialysis (10 females, 10 males) with dialysate calcium concentrations of 1.75 mmol/L were enrolled. At the start of the study, the dialysate calcium level was lowered to 1.50 mmol/L. Serial changes in biochemical, hemodynamic, and arterial stiffness parameters, including pulse wave velocity (PWV) and augmentation index (AIx), were assessed every 2 months for 6 months. We also examined changes in the calcification-inhibitory protein, serum fetuin-A.

Results: During the 6-month study period, serum total calcium and ionized calcium decreased consistently (9.5 ± 1.0 to 9.0 ± 0.7, p = 0.002 vs. 1.3 ± 0.1 to 1.1 ± 0.1, p = 0.035). Although no apparent changes in blood pressure were observed, heart-femoral PWW (hf-PWV) and AIx showed significant improvement (p = 0.012, 0.043, respectively). Repeated-measures ANOVA indicated a significant effect of lowering dialysate calcium on hf-PWV (F = 4.58, p = 0.004) and AIx (F = 2.55, p = 0.049). Accompanying the change in serum calcium, serum fetuin-A levels significantly increased (95.8 ± 45.8 pmol/mL at baseline to 124.9 ± 82.2 pmol/mL at 6 months, p = 0.043).

Conclusions: Lowering dialysate calcium concentration significantly improved arterial stiffness parameters, which may have been associated with upregulation of serum fetuin-A.

Keywords: Arterial stiffness; Calcium; Dialysis solutions; Fetuin A; Hemodialysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Analysis of Variance
  • Ankle Brachial Index
  • Arteries / drug effects*
  • Arteries / physiopathology
  • Biomarkers / blood
  • Blood Pressure / drug effects
  • Calcium / administration & dosage*
  • Calcium / adverse effects
  • Compliance
  • Female
  • Hemodialysis Solutions / administration & dosage*
  • Hemodialysis Solutions / adverse effects
  • Hemodialysis Solutions / chemistry
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Pulsatile Flow / drug effects*
  • Renal Dialysis*
  • Republic of Korea
  • Time Factors
  • Treatment Outcome
  • alpha-2-HS-Glycoprotein / metabolism

Substances

  • AHSG protein, human
  • Biomarkers
  • Hemodialysis Solutions
  • alpha-2-HS-Glycoprotein
  • Calcium